Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Takahashi, Yuko ^a   Haga, Shiori ^a   Ishizaka, Yukihito ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; AUTOANTIBODY; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; PREDNISOLONE; PROSTACYCLIN; RECOMBINANT ANGIOTENSIN CONVERTING ENZYME 2; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; ISCHEMIA; MALE; MIXED CONNECTIVE TISSUE DISEASE; PERSISTENT DIGITAL ISCHEMIA; PLASMAPHERESIS; PROTEIN PURIFICATION; PULMONARY HYPERTENSION; SCLERODERMA; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; BLOOD; CASE CONTROL STUDY; HEART MUSCLE ISCHEMIA; IMMUNOLOGY; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; SYSTEMIC SCLEROSIS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYOCARDIAL ISCHEMIA; PEPTIDYL-DIPEPTIDASE A; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SCLERODERMA, SYSTEMIC; VASCULAR DISEASES;

EID: 79851513938     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3013     Document Type: Article

References (19)

1. Vaz-Silva I, Carneiro MM, Ferreria MC, Pinheiro SV, Silva DA, Silva-Fillo AL, Witz CA, Reis AM, Santos RA, Reis FM. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endothelium. Reprod Sci 2009, 16:247-256. 10.1177/1933719108327593, 19164480.
2. Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 2009, 18:79-84. 10.1097/MNH.0b013e32831b70ad, 19077694.
3. Iwanami J, Mogi M, Iwai M, Horiuchi M. Inhibition of the renin-angiotensin system and target organ protection. Hypertens Res 2009, 32:229-327. 10.1038/hr.2009.5, 19262496.
4. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreria AI, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 2008, 103:1319-1326. 10.1161/CIRCRESAHA.108.184911, 18845809.
5. Ferreria AI, Shenoy V, Yamazato Y, Sriamula S, Francis J, Yuan L, Castellano RK, Ostrov DA, Oh SP, Katovich MJ, Raizada MK. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 2009, 179:1048-1054. 10.1164/rccm.200811-1678OC, 2689912, 19246717.
6. Yamazato Y, Ferreira AJ, Hong KH, Sriramula S, Francis J, Yamazato M, Yuan L, Bradford CN, Shenoy V, Oh SP, Katovich MJ, Raizada MK. Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer. Hypertension 2009, 54:365-371. 10.1161/HYPERTENSIONAHA.108.125468, 19564552.
7. Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 2008, 58:521-531. 10.1002/art.23303, 18240255.
8. Langleben D, Orhanos SE, Giovinazzo M, Hirsch A, Baron M, Seneal IL, Armaganidis A, Catravas JD. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Arthritis Rheum 2008, 58:1156-1164. 10.1002/art.23405, 18383374.
9. Kasparian A, Floros A, Gialafos E, Kanakis M, Tassiopoulos S, Kafasi S, Vaiopoulos G. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007, 16:505-508. 10.1177/0961203307080629, 17670849.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
11. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
12. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. Mixed Connective Tissue Disease and Anti-nuclear Antibodies 1987, 41-47. Amsterdam: Elsevier, Kasukawa R, Sharp GC.
13. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52:148-159. 10.1016/0002-9343(72)90064-2, 4621694.
14. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277:14838-14843. 10.1074/jbc.M200581200, 11815627.
15. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D. ACE and ACE2 activity in diabetic mice. Diabetes 2006, 55:3132-3139. 10.2337/db06-0033, 16804085.
16. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006, 130:182-189. 10.1378/chest.130.1.182, 16840400.
17. Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 2002, 29:282-287.
18. Galie N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani M-L, Branzi A. A meta-analysis of randomized control trials in pulmonary arterial hypertension. Eur Heart J 2009, 30:394-403. 10.1093/eurheartj/ehp022, 2642921, 19155250.
19. Matucci-Cerinic M, Seibold J-R. Digital ulcers and outcomes assessment in scleroderma. Rheumatology 2008, 47(Suppl 5):v46-v47. 10.1093/rheumatology/ken310, 18784143.